Cargando…
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
The World Health Organization (WHO) announced in March a pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was named Coronavirus Disease 19 (COVID-19), and at October 2020, more than 39,000,000 cases of SARS-CoV-2 have been detected worldwid...
Autores principales: | Canedo-Marroquín, Gisela, Saavedra, Farides, Andrade, Catalina A., Berrios, Roslye V., Rodríguez-Guilarte, Linmar, Opazo, María C., Riedel, Claudia A., Kalergis, Alexis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759609/ https://www.ncbi.nlm.nih.gov/pubmed/33362758 http://dx.doi.org/10.3389/fimmu.2020.569760 |
Ejemplares similares
-
Molecular and Cellular Mechanisms Modulating Trained Immunity by Various Cell Types in Response to Pathogen Encounter
por: Acevedo, Orlando A., et al.
Publicado: (2021) -
LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections
por: Rodríguez-Guilarte, Linmar, et al.
Publicado: (2023) -
Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023) -
The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses
por: Soto, Jorge A., et al.
Publicado: (2020) -
Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection
por: Bohmwald, Karen, et al.
Publicado: (2019)